Cell-based evaluation of changes in coagulation activity induced by antineoplastic drugs for the treatment of acute myeloid leukemia

Idarubicin (IDR), cytarabine (AraC), and tamibarotene (Am80) are effective for treatment of acute myeloid leukemia (AML). In acute leukemia, the incidence of venous thromboembolism or disseminated intravascular coagulation is associated with induction chemotherapy. Procoagulant effects of IDR, AraC,...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsunaka, Misae, Shinki, Haruka, Koyama, Takatoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5391104/
https://www.ncbi.nlm.nih.gov/pubmed/28406995
http://dx.doi.org/10.1371/journal.pone.0175765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5391104/
https://www.ncbi.nlm.nih.gov/pubmed/28406995
http://dx.doi.org/10.1371/journal.pone.0175765

Ejemplares similares